XML 78 R61.htm IDEA: XBRL DOCUMENT v3.23.1
SHAREHOLDERS' EQUITY - Narrative (Details)
12 Months Ended 46 Months Ended
Nov. 17, 2022
USD ($)
$ / shares
shares
Feb. 04, 2020
USD ($)
sales_agent
Jul. 18, 2011
Mar. 31, 2023
USD ($)
$ / shares
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Aug. 31, 2022
USD ($)
Aug. 02, 2022
USD ($)
Aug. 01, 2022
USD ($)
Jul. 28, 2021
USD ($)
May 26, 2021
USD ($)
Mar. 04, 2019
USD ($)
Subsidiary or Equity Method Investee [Line Items]                        
Right to grant period     10 years                  
Repurchase authorized amount             $ 20,000,000     $ 20,000,000    
Public Equity Offering                        
Subsidiary or Equity Method Investee [Line Items]                        
Number of shares sold (in shares) | shares 2,534,436                      
Par value, common stock (in usd per share) | $ / shares $ 18.15                      
Gross proceeds received $ 46,000,000                      
Net proceeds received $ 44,100,000                      
Equity ATM Program                        
Subsidiary or Equity Method Investee [Line Items]                        
Number of shares sold (in shares) | shares       8,435,462 3,872,031 16,613,122            
Gross proceeds received       $ 161,216,000 $ 99,636,000 $ 344,700,000            
Net proceeds received       $ 158,798,000 $ 98,142,000 $ 339,100,000            
Maximum consideration threshold   $ 100,000,000           $ 650,000,000 $ 250,000,000   $ 250,000,000 $ 50,000,000
Number of additional sales agents | sales_agent   2                    
Gross sales commission percentage                     1.50% 2.00%
Weighted average price per share (in usd per share) | $ / shares       $ 19.11 $ 25.73 $ 20.75            
Available under the Equity ATM Program       $ 305,300,000                
2010 Plan | Restricted Stock                        
Subsidiary or Equity Method Investee [Line Items]                        
Right to grant period     10 years